These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 19106712)

  • 1. Hyperlipidaemia and cardiovascular disease: nonlipid-lowering effects of omega-3 fatty acids, statins and fibrates.
    Dominiczak M
    Curr Opin Lipidol; 2009 Feb; 20(1):79-81. PubMed ID: 19106712
    [No Abstract]   [Full Text] [Related]  

  • 2. Beyond blood lipids: phytosterols, statins and omega-3 polyunsaturated fatty acid therapy for hyperlipidemia.
    Micallef MA; Garg ML
    J Nutr Biochem; 2009 Dec; 20(12):927-39. PubMed ID: 19733044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease.
    Staels B; Maes M; Zambon A
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):542-53. PubMed ID: 18628776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for reducing cardiovascular risk in patients with hypertriglyceridemia.
    Gorkin JU; Watson K; Knopp RH
    J Fam Pract; 2007 Aug; 56(8 Suppl Strategies):S1-7; quiz S8. PubMed ID: 18667138
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperlipidaemia and cardiovascular disease: low HDL-cholesterol as a therapeutic target in statin-treated patients: a role for nicotinic acid (niacin)?
    Choudhury RP
    Curr Opin Lipidol; 2010 Apr; 21(2):161-2. PubMed ID: 20616630
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypertriglyceridemia and cardiovascular disease management.
    Codario RA
    J Am Acad Nurse Pract; 2007; 19(12 Suppl 2):7-10, 13-4. PubMed ID: 18510282
    [No Abstract]   [Full Text] [Related]  

  • 7. Is there evidence-based hypolipidemic treatment with clinical benefit beyond statins?
    Goumas GS
    Angiology; 2009; 60(1):93-8. PubMed ID: 19019838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FPIN's clinical inquiries. Best alternatives to statins for treating hyperlipidemia.
    Bouknight P; Mackler L; Heffington M
    Am Fam Physician; 2007 Oct; 76(7):1027-9. PubMed ID: 17956075
    [No Abstract]   [Full Text] [Related]  

  • 9. Managing dyslipidemia in chronic kidney disease.
    Harper CR; Jacobson TA
    J Am Coll Cardiol; 2008 Jun; 51(25):2375-84. PubMed ID: 18565393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid management in the geriatric patient.
    Nair AP; Darrow B
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):185-206. PubMed ID: 19217519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-talk between statins and PPARalpha in cardiovascular diseases: clinical evidence and basic mechanisms.
    Paumelle R; Staels B
    Trends Cardiovasc Med; 2008 Apr; 18(3):73-8. PubMed ID: 18436144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperlipidemia].
    Wakatsuki A
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():375-80. PubMed ID: 16689337
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of dyslipidemia in patients with complicated metabolic syndrome.
    Davidson MH
    Am J Cardiol; 2005 Aug; 96(4A):22E-25E. PubMed ID: 16098839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy and clinical trials: metabolic syndrome and cardiovascular risk management.
    Edavalath M; Rees A
    Curr Opin Lipidol; 2008 Aug; 19(4):438-9. PubMed ID: 18607195
    [No Abstract]   [Full Text] [Related]  

  • 15. Statins: another class of antihypertensive agents?
    Milionis HJ; Liberopoulos EN; Achimastos A; Elisaf MS; Mikhailidis DP
    J Hum Hypertens; 2006 May; 20(5):320-35. PubMed ID: 16511505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Statins and their pleiotropic effects].
    Galus R; Zandecki Ł; Jóźwiak J; Włodarski K
    Pol Merkur Lekarski; 2008 Jun; 24(144):545-8. PubMed ID: 18702340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of dyslipidemia].
    Cybulska B
    Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():11-2. PubMed ID: 12621774
    [No Abstract]   [Full Text] [Related]  

  • 18. [Similarities, differences and agonisms of pleiotropic effects of statins and omega-3 fatty acids].
    Villalobos ME; Sánchez-Muniz FJ; Acín MT; Vaquero MP; Higueras FJ; Bastida S
    Nutr Hosp; 2010; 25(6):889-909. PubMed ID: 21519759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperlipidaemia and cardiovascular disease: statin update.
    Roberts AW; Salim M
    Curr Opin Lipidol; 2007 Jun; 18(3):381-3. PubMed ID: 17495613
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative effects of lipid-lowering therapies.
    Davidson MH; Toth PP
    Prog Cardiovasc Dis; 2004; 47(2):73-104. PubMed ID: 15586350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.